These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 13927395)

  • 1. [Experimental studies on the cancerogenic effect of iron dextran (ursoferran)].
    KUNZ J; SHAHAB L; HENZE K; DAVID H
    Acta Biol Med Ger; 1963; 10():602-14. PubMed ID: 13927395
    [No Abstract]   [Full Text] [Related]  

  • 2. IRON-DEXTRAN CARCINOGENESIS IN RATS: EFFECT OF DISTRIBUTING INJECTED MATERIAL BETWEEN ONE, TWO, FOUR, OR SIX SITES.
    ROE FJ; HADDOW A; DUKES CE; MITCHLEY BC
    Br J Cancer; 1964 Dec; 18(4):801-8. PubMed ID: 14264947
    [No Abstract]   [Full Text] [Related]  

  • 3. INDUCTION OF SARCOMATA IN RABBITS BY INTRAMUSCULAR INJECTION OF IRON-DEXTRAN ("IMFERON").
    HADDOW A; ROE FJ; MITCHLEY BC
    Br Med J; 1964 Jun; 1(5398):1593-4. PubMed ID: 14141626
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current knowledge of the presumed carcinogenic power of the iron-dextran complex (Imferon)].
    LAYRISSE M
    Rev Obstet Ginecol Venez; 1961; 21():307-13. PubMed ID: 14463059
    [No Abstract]   [Full Text] [Related]  

  • 5. [Research on the in vivo carcinogenic activity of an iron-dextran complex in the rat].
    VIALLIER J; REBOUILLAT M
    C R Seances Soc Biol Fil; 1962; 156():691-3. PubMed ID: 13925738
    [No Abstract]   [Full Text] [Related]  

  • 6. [AUTORADIOGRAPHIC STUDIES ON MAST CELLS IN IRON DEXTRAN-INDUCED SARCOMA].
    KUNZ J
    Acta Biol Med Ger; 1964; 13():233-8. PubMed ID: 14205277
    [No Abstract]   [Full Text] [Related]  

  • 7. The carcinogenicity of an iron-dextran complex.
    RICHMOND HG
    Cancer Prog; 1960; ():24-33. PubMed ID: 13741355
    [No Abstract]   [Full Text] [Related]  

  • 8. MORPHOLOGICAL EFFECTS OF IRON-DEXTRAN ON FOWL FIBROCYTES IN VITRO.
    TURNER CJ
    Br J Cancer; 1963 Dec; 17(4):731-7. PubMed ID: 14111613
    [No Abstract]   [Full Text] [Related]  

  • 9. On the carcinogenicity of an iron-dextran complex.
    HADDOW A; HORNING ES
    J Natl Cancer Inst; 1960 Jan; 24():109-47. PubMed ID: 13830749
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction of sarcoma in the rat by iron-dextran complex.
    RICHMOND HG
    Br Med J; 1959 Apr; 1(5127):947-9. PubMed ID: 13638595
    [No Abstract]   [Full Text] [Related]  

  • 11. CARCINOGENIC RISK OF IRON-DEXTRAN.
    GIUFFRIDA G; CONDORELLI M; FILOCAMO G; MIGLIAU G; PUGLIESE F; BASILE U
    Br Med J; 1964 Jun; 1(5398):1583-4. PubMed ID: 14134484
    [No Abstract]   [Full Text] [Related]  

  • 12. CARCINOGENIC risks of iron-dextran.
    Br Med J; 1960 Mar; 1(5175):788-9. PubMed ID: 13856802
    [No Abstract]   [Full Text] [Related]  

  • 13. [THE EFFECT OF IRON INJECTIONS IN ANIMAL EXPERIMENTS].
    GOLBERG L
    Arzneimittelforschung; 1963 Nov; 13():939-45. PubMed ID: 14210427
    [No Abstract]   [Full Text] [Related]  

  • 14. The toxic effects of iron-dextran complex on mammalian cells in tissue culture.
    RICHMOND HG
    Br J Cancer; 1961 Sep; 15(3):594-606. PubMed ID: 14492016
    [No Abstract]   [Full Text] [Related]  

  • 15. Iron-dextran carcinogenesis in rats: influence of dose on the number and types of neoplasm induced.
    Roe FJ; Carter RL
    Int J Cancer; 1967 Jul; 2(4):370-80. PubMed ID: 6055974
    [No Abstract]   [Full Text] [Related]  

  • 16. Iron-dextran induction of distant tumours in mice.
    Langvad E
    Int J Cancer; 1968 Jul; 3(4):415-23. PubMed ID: 4879897
    [No Abstract]   [Full Text] [Related]  

  • 17. THE RISK OF SARCOMATOUS CHANGE AFTER IRON-DEXTRAN THERAPY.
    CHANDRA RK
    Indian J Pediatr; 1965 Feb; 32():75-7. PubMed ID: 14281290
    [No Abstract]   [Full Text] [Related]  

  • 18. [THE TOLERANCE OF IRON THERAPY WITH SPECIAL REFERENCE TO THE CARCINOGENIC EFFECT OF THE DEXTRAN-IRON COMPLEX].
    THEDERING F
    Med Welt; 1964 Feb; 6():277-82. PubMed ID: 14140207
    [No Abstract]   [Full Text] [Related]  

  • 19. IRON-DEXTRAN AND SARCOMATA.
    GILLIE A
    Br Med J; 1964 Jul; 2(5401):119-21. PubMed ID: 14147762
    [No Abstract]   [Full Text] [Related]  

  • 20. Massive and prolonged administration of iron-dextran complex.
    FOYE LV; FEICHTMEIR TV
    N Engl J Med; 1961 Apr; 264():859-61. PubMed ID: 13701137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.